» Authors » Torbjorn Wisloff

Torbjorn Wisloff

Explore the profile of Torbjorn Wisloff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 79
Citations 754
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hansen B, Klungsoyr O, Labberton A, Saaksvuori L, Rydland K, Odeskaug L, et al.
JMIR Res Protoc . 2025 Feb; 14:e63938. PMID: 39998878
Background: The coverage of influenza vaccination among older adults in Norway is insufficient, especially in some immigrant groups. To improve public health, there is a need for an intervention that...
2.
Johansen S, Wisloff T, Edvardsen E, Kollerud S, Jensen J, Agwu G, et al.
JACC CardioOncol . 2025 Feb; 7(2):96-106. PMID: 39967210
Background: Poor cardiorespiratory fitness (CRF) is associated with a higher symptom burden and an increased prevalence of long-term treatment-related cardiovascular disease risk factors in cancer survivors. However, the magnitude of...
3.
Edwin G, Skraastad B, Hisdal J, Wisloff T, Sundhagen J, Kazmi S
Vasc Health Risk Manag . 2025 Feb; 21:61-69. PMID: 39963255
Introduction: Previous studies with visible light spectroscopy (VLS) and laser Doppler flowmetry (LDF) have shown reduced mucosal circulation of the stomach and duodenal wall in patients with median arcuate ligament...
4.
Andreasen C, Dahl C, Frihagen F, Borgen T, Basso T, Gjertsen J, et al.
Osteoporos Int . 2025 Jan; 36(3):501-512. PMID: 39808195
Purpose: Efficient fracture prevention strategies are warranted to control the global fracture burden. We investigated the effect of a standardized fracture liaison service (FLS) intervention on subsequent fracture risk and...
5.
Vo C, Wilsgaard T, Samuelsen P, Mathiesen E, Sommerseth H, Eggen A, et al.
BMJ Open . 2024 Dec; 14(12):e089819. PMID: 39725421
Objectives: There is limited evidence regarding the impact of lipid-lowering drugs (LLDs) on the socioeconomic gradient in a longitudinal perspective. The study investigates the longitudinal socioeconomic gradient in total cholesterol...
6.
Omland T, Rosjo H, Wisloff T, Bernard M, Hiltbold A, Khatib S, et al.
Clin Biochem . 2024 Dec; 135():110868. PMID: 39706544
Background: Secretoneurin, a member of the granin protein family, is associated with the risk of mortality in patients with acute and chronic heart failure. Secretoneurin may play an important role...
7.
Vazquez Fernandez L, Diz-Lois Palomares A, Vicedo-Cabrera A, Gasparrini A, Freiesleben De Blasio B, Di Ruscio F, et al.
Environ Res . 2024 Dec; 266():120614. PMID: 39672493
Background & Aim: Understanding local vulnerability to heat and cold is crucial for public health planning, yet few studies have provided a nationwide analysis of temperature-related mortality across diverse communities....
8.
Frigaard C, Menichetti J, Schirmer H, Bjornstad H, Breines Simonsen T, Wisloff T, et al.
BMJ Open . 2024 Aug; 14(8):e086440. PMID: 39117414
Objectives: The main objective of this study was twofold: to investigate what kind of information patients with heart failure (HF) tell their doctors about their medication adherence at home, and...
9.
Aziz A, Dudman S, Julin C, Ahmmed F, Stene-Johansen K, Sandbu S, et al.
Lancet Glob Health . 2024 Jul; 12(8):e1300-e1311. PMID: 39030061
Background: Vaccination constitutes an attractive control measure for hepatitis E virus (HEV), a major cause of maternal and perinatal mortality globally. Analysis of pregnant participants in an effectiveness trial of...
10.
Mecinaj A, Gulati G, Ree A, Gravdehaug B, Rosjo H, Steine K, et al.
JACC CardioOncol . 2024 Mar; 6(1):83-95. PMID: 38510299
Background: The impact of recent consensus definitions of cancer therapy-related cardiac dysfunction (CTRCD) from the European Society of Cardiology cardio-oncology guidelines on the reported incidence of CTRCD has not yet...